Search
for

    Research 10 of 154

    1. Expression of AR, 5αR1 and 5αR2 in bladder urothelial carcinoma and relationship to clinicopathological factors Life sciences · 2017 · 13 citations
    2. 5α-reductase inhibitors impact prognosis of urothelial carcinoma BMC Cancer · 2020 · 23 citations
    3. Polypoid Cystitis and Bilateral Hydronephrosis Mimicking Urothelial Carcinoma Journal of endourology case reports · 2019 · 3 citations
    4. Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive? Clinical genitourinary cancer · 2019 · 9 citations
    5. Bladder Cancer: The Hormonal Dependence Enigma and a New Hormonal Player Indian Journal of Surgery · 2014 · 3 citations
    6. Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system Frontiers in Medicine · 2026
    7. Neoadjuvant therapy with Disitamab vedotin in treating muscle-invasive bladder cancer: A case report Heliyon · 2023 · 1 citations
    8. Forum Pharmaceutical Medicine · 2012
    9. The Molecular Pathogenesis of Trichilemmal Carcinoma Research Square (Research Square) · 2020
    10. The Molecular Pathogenesis of Trichilemmal Carcinoma Research Square (Research Square) · 2020
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →